Skip to content

Plasma markers in patients with mild cognitive impairment and early Alzheimer's disease

Plasma markers in patients with mild cognitive impairment and early Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082165
Enrollment
Unknown
Registered
2024-03-22
Start date
2024-03-25
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Control group:None

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of AD group: A. Meet the diagnostic criteria of "probable Alzheimer's disease with mild tomoderate dementia" in NINCDS-ADRDA; B. Chinese Han nationality, male or female, age = 60 years old, with good visual and auditory function; C. Voluntary participation in the study. Inclusion criteria of MCI group: A. Comply with Petersen's diagnostic criteria; B. Chinese Han nationality, male or female, age = 60 years old, with good audiovisual function; C. Voluntary participation in the study. Inclusion criteria for the control group: A. Chinese Han nationality, male or female, B. Age = 60 years, good audiovisual function, no cognitive dysfunction; C. Voluntary participation in the study.

Exclusion criteria

Exclusion criteria: A. A clear diagnosis of moderate to advanced dementia or severe mental illness; B. Neurological disorders such as stroke, traumatic brain injury, epilepsy, etc.; C. Severe chronic physical illness.

Design outcomes

Primary

MeasureTime frame
Plasma biomarker;

Secondary

MeasureTime frame
APOE gene;

Countries

China

Contacts

Public ContactWu Yue

Wuxi Mental Health Center

wuxiwuyue@163.com+86 133 5811 9039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026